Legal & General Group PLC Vor Biopharma Inc. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.09 - $5.33 $11,207 - $19,331	3,627 New	3,627 $11,000
Q2 2022 Aug 22, 2022	SELL	$3.89 - $6.44 $6,041 - $10,001	-1,553 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.24 - $20.38 $7,123 - $11,861	582 Added 59.94%	1,553 $24,000
Q2 2021 Aug 12, 2021	SELL	$18.65 - $38.78 $3,823 - $7,949	-205 Reduced 17.43%	971 $18,000
Q1 2021 May 17, 2021	BUY	$30.96 - $54.08 $36,408 - $63,598	1,176 New	1,176 $51,000

47.9M

1.5K

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $24.4M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.